Company
We are driven to find better, bolder approaches to drug discovery that will ultimately transform the way we think about disease. We are Valo.
Lisa Young
Board Director
David Mauney, MD
Ron Hovsepian
Robert Fine
David R. Epstein
Paul Biondi, MBA
Executive Chairman of the Board of Directors, and Interim CEO
Harsha Ramalingam, MBA
Chris Schade